Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Loans and fees receivable, gross	$ 400,700	$ 393,900
Loans and Leases Receivable, Net Amount	315,720	305,081
Assets
Unrestricted cash and cash equivalents	35,414	41,484
Restricted cash and cash equivalents	31,240	29,174
Property at cost, net of depreciation	3,021	3,229
Investment in equity-method investee	3,561	4,244
Deposits	272	252
Prepaid expenses and other assets	43,684	42,149
Total assets	432,912	425,613
Liabilities
Accounts payable and accrued expenses	114,709	115,737
Notes Payable to Bank	242,130	226,238
Notes Payable, Related Parties	40,000	40,000
Notes payable associated with structured financings, at fair value	7,909	9,240
Convertible senior notes	61,650	61,393
Income tax liability	9,465	9,132
Total liabilities	475,863	461,740
Commitments and contingencies (Note 9)
Equity
Common stock, no par value, 150,000,000 shares authorized: 15,353,878 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at March 31, 2018; and 15,291,884 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at December 31, 2017	0	0
Additional paid-in capital	213,025	212,785
Accumulated other comprehensive loss	(4,523)	(2,178)
Retained deficit	(251,310)	(246,640)
Total shareholders’ equity	(42,808)	(36,033)
Noncontrolling interests	(143)	(94)
Total equity	(42,951)	(36,127)
Total liabilities and equity	432,912	425,613
Loans Receivable [Member]
Loans and Fees Receivable, at Fair Value	9,413	11,109
Loans and fees receivable, gross	400,727	393,898
Loans and Leases Receivable, Allowance	(58,323)	(62,970)
Loans and Leases Receivable, Deferred Income	$ 36,097	$ 36,956